Loss of Y Chromosome in Peripheral Blood of Colorectal and Prostate Cancer Patients
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Although age-related loss of chromosome Y (LOY) in normal hematopoietic cells is a well-known phenomenon, the phenotypic consequences of LOY have been elusive. However, LOY has been found in association with smoking, shorter survival and higher risk of cancer. It was suggested that LOY in blood cells could become a predictive biomarker of male carcinogenesis. AIMS, METHODS & FINDINGS: To investigate the association of LOY in blood cells with the risk for development of colorectal (CC) and prostate cancers (PC), we have analyzed DNA samples from peripheral blood of 101 CC male patients (mean age 60.5±11.9 yrs), 70 PC patients (mean age 68.8±8.0 yrs) and 93 healthy control males (mean age 65.8±16.6 yrs). The methodology included co-amplification of homologous sequences on chromosome Y and other chromosomes using multiplex quantitative fluorescent (QF) PCR followed by automatic detection and analysis on ABI 3500 Genetic Analyzer. The mean Y/X ratio was significantly lower in the whole group of cancer patients (0.907±0.12; p = 1.17x10-9) in comparison to the controls (1.015±0.15), as well as in CC (0.884±0.15; p = 3.76x10-9) and PC patients (0.941±0.06; p = 0.00012), when analyzed separately. Multivariate logistic regression analysis adjusting for LOY and age showed that LOY is a more significant predictor of cancer presence than age, and that age probably does not contribute to the increased number of subjects with detectable LOY in cancer patients cohort. CONCLUSION: In conclusion, our results support the recent findings of association of LOY in blood cells with carcinogenesis in males.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Age-related clonal hematopoiesis associated with adverse outcomes
Jaiswal, S., Fontanillas, P., Flannick, J., Manning, A., Grauman, P. V., Mar, B. G., Lindsley, R. C., Mermel, C. H., Burtt, N., Chavez, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408617 · Cited by 4,841 · cited 1×
“Recently, clonal hematopoiesis with somatic mutations was shown not only to be increasingly common in elderly people but also to increase the risk of hematological malignancies and death [36,37], with the possibility that all-cause mortality is due to an increased risk of cardiovascular disease [36].”
BackgroundClonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence
Genovese, G., Kähler, A. K., Handsaker, R. E., Lindberg, J., Rose, S. A., Bakhoum, S. F., Chambert, K., Mick, E., Neale, B. M., Fromer, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409405 · Cited by 3,531 · cited 1×
“Recently, clonal hematopoiesis with somatic mutations was shown not only to be increasingly common in elderly people but also to increase the risk of hematological malignancies and death [36,37], with the possibility that all-cause mortality is due to an increased risk of cardiovascular disease [36].”
BackgroundDetectable clonal mosaicism and its relationship to aging and cancer
Jacobs, K. B., Yeager, M., Zhou, W., Wacholder, S., Wang, Z., Rodriguez-Santiago, B., Hutchinson, A., Deng, X., Liu, C., Horner, M.-J., et al. (2012) · Nature Genetics · doi:10.1038/ng.2270 · Cited by 589 · cited 1×
“Also, large chromosomal abnormalities (>2Mb) of autosomes in DNA from blood were found to be more frequent among individuals with solid tumors than in cancer-free individuals [38].”
Background
Cited by
Genetic predisposition to mosaic Y chromosome loss in blood
International Lung Cancer Consortium (INTEGRAL-ILCCO), Thompson, D. J., The Breast Cancer Association Consortium, Consortium of Investigators of Modifiers of BRCA1/2, The Endometrial Cancer Association Consortium, The Ovarian Cancer Association Consortium, The Prostate Cancer Association Group to Investigate Cancer Associated Alterations in the Genome (PRACTICAL) Consortium, The Kidney Cancer GWAS Meta-Analysis Project, eQTLGen Consortium, Biobank-based Integrative Omics Study (BIOS) Consortium, et al. (2019) · Nature · doi:10.1038/s41586-019-1765-3 · Cited by 337
Mosaic Loss of Chromosome y in Blood Is Associated with Alzheimer Disease
Dumanski, J. P., Lambert, J.-C., Rasi, C., Giedraitis, V., Davies, H., Grenier-Boley, B., Lindgren, C. M., Campion, D., Dufouil, C., Pasquier, F., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.05.014 · Cited by 266
“The above-mentioned results regarding LOY and cancer risk have recently been extended to several specific cancer diagnoses.(36,37) It should also be mentioned that LOY has been suggested to be involved in the pathogenesis of rare autoimmune diseases in males, such as autoimmune thyroiditis and primary biliary cirrhosi…”
ResultMosaicism in health and disease — clones picking up speed
Forsberg, L. A., Gisselsson, D., & Dumanski, J. P. (2017) · Nature Reviews Genetics · doi:10.1038/nrg.2016.145 · Cited by 263
Forsberg, L. A. (2017) · Human Genetics · doi:10.1007/s00439-017-1799-2 · Cited by 134
“Commonly used platforms include SNP arrays, different forms of quantitative PCR, as well as next-generation sequencing (NGS).”
BackgroundMethodInfluentialHaitjema, S., Kofink, D., van Setten, J., van der Laan, S. W., Schoneveld, A. H., Eales, J., Tomaszewski, M., de Jager, S. C. A., Pasterkamp, G., Asselbergs, F. W., et al. (2017) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.116.001544 · Cited by 123
“Only recently, LOY was associated with a higher risk of (nonhematological) cancer and overall mortality.(2,3) This relationship was speculated to be because of smoking and a disrupted tumor immunosurveillance.”
Concurrent loss of the Y chromosome in cancer and T cells impacts outcome
Chen, X., Shen, Y., Choi, S., Abdel-Hafiz, H. A., Basu, M., Hoelzen, L., Tufano, M., Kailasam Mani, S. K., Ranjpour, M., Zhu, J., et al. (2025) · Nature · doi:10.1038/s41586-025-09071-2 · Cited by 50
“LOY in PBMCs is the most common somatic alteration in healthy men and has been associated with increased risk 8,9 and mortality from cancer 1–3 .”
Metadata
- Authors
- Noveski, P., Madjunkova, S., Sukarova Stefanovska, E., Matevska Geshkovska, N., Kuzmanovska, M., Dimovski, A., & Plaseska-Karanfilska, D.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2016-01-08
- Volume
- 11
- Issue
- 1
- Pages
- e0146264
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2222141405
- Cited by
- 102
- References
- 3
- FWCI
- 8.32
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.